A carregar...
Radiopharmaceuticals for Relapsed or Refractory Ovarian Cancers
Targeted radiopharmaceuticals for therapeutic use deliver radionuclides directly to tumor anywhere in the body, and therefore, have renewed interest for clinical development in women with disseminated chemorefractory ovarian cancers. About two in every five women with advanced stage ovarian cancer o...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448015/ https://ncbi.nlm.nih.gov/pubmed/30984615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00180 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|